hers glp 1 reviews

Last updated: September 25, 2026

Quick Answer

Hers GLP-1 is a telehealth-based weight loss program that prescribes compounded semaglutide to eligible women, delivered directly to their door after an online consultation. Based on real user experiences and available clinical data on semaglutide, many users report meaningful appetite reduction and gradual weight loss, though results vary significantly by individual. It is a legitimate medical service, but it is not right for everyone, and understanding the full picture before signing up matters.

---

Key Takeaways

• Hers GLP-1 uses compounded semaglutide, a GLP-1 receptor agonist that reduces appetite and slows digestion to support weight loss.
• Most users in Hers GLP-1 reviews report noticeable appetite suppression within the first two to four weeks.
• Pricing is typically lower than brand-name options like Ozempic or Wegovy, but it is still an out-of-pocket expense for most users.
• Common side effects include nausea, fatigue, and digestive discomfort, especially during dose escalation.
• Hers GLP-1 is best suited to adult women with a BMI of 27 or higher who have not responded well to diet and exercise alone.
• Insurance rarely covers compounded GLP-1 medications, so most users pay monthly subscription fees directly.
• Results typically become visible between weeks four and twelve, with more significant changes by month three.
• Compounded semaglutide differs from FDA-approved branded versions in manufacturing source, though the active molecule is the same.
• Getting a prescription requires completing an online health intake form reviewed by a licensed clinician.
• Alternatives include Noom Med, Ro Body, Found, and Henry Meds, each with different pricing and medication options.

---

What Is Hers GLP-1 and How Does It Work

Hers GLP-1 is a prescription weight management program offered through the Hers telehealth platform, specifically designed for women. It provides access to compounded semaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist, through an online consultation process that connects users with licensed clinicians.

GLP-1 receptor agonists work by mimicking a naturally occurring gut hormone that the body releases after eating. Here is what happens when semaglutide is active in your system:

• Appetite suppression: It signals the brain’s hunger centers to reduce food cravings and portion sizes.
• Slowed gastric emptying: Food moves more slowly through the stomach, which extends the feeling of fullness after meals.
• Improved insulin response: It stimulates the pancreas to release insulin in response to blood sugar, which helps stabilize energy levels.
• Reduced caloric intake: Because hunger decreases, most users naturally eat less without feeling deprived.

The semaglutide in the Hers program is compounded, meaning it is prepared by a licensed compounding pharmacy rather than manufactured by a brand-name pharmaceutical company. The active molecule is chemically identical to the one in Ozempic and Wegovy, but compounded versions are not FDA-approved finished drug products. They are, however, legally prescribed and dispensed under specific regulatory conditions.

For a broader look at how semaglutide performs across different delivery methods, see these semaglutide tablets reviews that cover oral formulations as a comparison point.

---

Hers GLP-1 Reviews: What Real Users Are Saying

Real-world Hers GLP-1 reviews from Reddit threads, app store feedback, and health forums paint a mixed but generally positive picture for users who stick with the program for at least two to three months.

Common positive themes in user reports:

• Significant reduction in appetite, often described as “food noise going quiet”
• Gradual but consistent weight loss averaging one to two pounds per week after the first month
• Convenience of the telehealth model, with no in-person clinic visits required
• Responsive customer support compared to some competitors

Common complaints in Hers GLP-1 reviews:

• Nausea during the first four to six weeks, particularly after dose increases
• Inconsistent shipping timelines reported by some users
• Frustration when clinicians deny eligibility based on intake form responses
• The monthly cost feels high for users who do not see results quickly

One user on a popular weight loss subreddit described her experience this way: “I was skeptical because I had tried everything. By week six, I had lost nine pounds and my late-night snacking basically stopped. The nausea was rough at first but manageable.” Another noted: “The process was easy, but I wish there was more ongoing support from the medical team beyond the initial consult.”

These experiences align closely with what clinical data shows for semaglutide generally. A landmark 2021 trial published in the New England Journal of Medicine (Wilding et al., 2021) found that adults using semaglutide lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% in the placebo group. Individual results through the Hers program will vary based on adherence, dosage, diet, and activity level.

For additional context on patient-reported outcomes with similar medications, the tirzepatide reviews by patients resource offers useful comparison data.

---

Hers GLP-1 Cost and Pricing: How Much Does It Actually Cost

Hers GLP-1 is an out-of-pocket expense for most users, as compounded semaglutide is rarely covered by insurance. Pricing as of 2026 typically falls in the range of $99 to $299 per month depending on the dosage tier and any promotional pricing applied at sign-up.

Dosage Tier	Estimated Monthly Cost	Notes
Starting dose (0.25 mg/week)	~$99,$149/month	Introductory tier, often discounted
Mid dose (0.5-1 mg/week)	~$149,$199/month	Most users land here after titration
Higher dose (1-2.4 mg/week)	~$199,$299/month	For users needing stronger suppression

Important pricing notes:

• Shipping is typically included in the monthly fee.
• The program operates on a subscription model, so you need to actively cancel to stop charges.
• A refund policy exists but varies by situation; check the current terms before subscribing.
• There is no insurance billing for compounded medications through this platform.

For users comparing costs across providers, this cheapest pharmacy for semaglutide rankings and reviews resource breaks down pricing across multiple telehealth and pharmacy options.

---

Hers GLP-1 vs Other Weight Loss Medications: Which Is Better

Hers GLP-1 competes directly with other telehealth GLP-1 programs and, indirectly, with brand-name medications. The right choice depends on your budget, health profile, and what level of clinical oversight you want.

Feature	Hers GLP-1	Wegovy (brand-name)	Ro Body / Found
Medication type	Compounded semaglutide	FDA-approved semaglutide	Compounded semaglutide or tirzepatide
Access model	Telehealth subscription	In-person or telehealth Rx	Telehealth subscription
Insurance coverage	Rarely covered	Sometimes covered	Rarely covered
Women-focused platform	Yes	No	No (gender-neutral)
Ongoing clinical check-ins	Limited (messaging-based)	Varies by prescriber	Structured coaching included

Choose Hers GLP-1 if you want a women-focused platform, prefer a fully online process, and are comfortable with compounded medication at a lower price point than brand-name options.

Consider alternatives if you want FDA-approved branded medication, prefer in-person clinical oversight, or need insurance billing support.

For a detailed look at another compounded option, the compounded semaglutide reviews with real patient stories article covers similar ground with additional patient perspectives.

---

Does Hers GLP-1 Really Work for Weight Loss

Yes, the evidence supports that semaglutide, the active ingredient in Hers GLP-1, produces meaningful weight loss in most eligible users who adhere to the program. The clinical evidence for semaglutide as a weight loss agent is among the strongest available for any non-surgical intervention.

Key evidence points:

• The STEP 1 trial (Wilding et al., New England Journal of Medicine, 2021) showed average weight loss of 14.9% over 68 weeks with 2.4 mg semaglutide weekly.
• A 2022 meta-analysis in Obesity Reviews confirmed that GLP-1 receptor agonists consistently outperform placebo for weight reduction across diverse populations.
• Real-world data from telehealth programs mirrors trial results at lower doses, though typically with more modest outcomes (5-10% body weight reduction at six months is a reasonable estimate for most users).

What affects whether it works for you:

• Adherence to the weekly injection schedule
• Diet quality (semaglutide reduces hunger but does not replace a calorie deficit)
• Starting dose and titration pace
• Individual metabolic response, which varies

---

Hers GLP-1 Side Effects: What Should You Expect

Most users experience at least some side effects, particularly during the first four to eight weeks as the body adjusts to semaglutide. These are generally manageable and tend to decrease over time.

Side Effect	How Common	What to Do
Nausea	Very common (40-50%)	Eat smaller meals, avoid fatty foods
Fatigue	Common	Usually resolves within weeks
Constipation or diarrhea	Common	Increase water and fiber intake
Injection site reactions	Occasional	Rotate injection sites
Headache	Occasional	Stay hydrated
Pancreatitis (rare)	Rare but serious	Seek immediate medical attention if severe abdominal pain occurs

Medical disclaimer: If you have a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pancreatitis, or gallbladder disease, discuss this with a clinician before starting any GLP-1 medication. Do not use semaglutide during pregnancy.

---

Who Is Hers GLP-1 Good For and Who Should Not Use It

Hers GLP-1 is designed for adult women, and eligibility is determined by a licensed clinician after reviewing your health intake form. It is not a one-size-fits-all solution.

Best suited for:

• Adult women with a BMI of 27 or higher, especially with a weight-related condition like high blood pressure or prediabetes
• Women who have tried diet and exercise without achieving sufficient results
• Those comfortable with weekly self-injections at home
• Users who prefer a fully digital healthcare experience

Not ideal for:

• Women who are pregnant or breastfeeding
• Those with a personal or family history of thyroid cancer or MEN2
• Users with active eating disorders
• Anyone expecting medication-level results without dietary changes
• People who need in-person clinical monitoring for complex health conditions

---

How Long Does It Take to See Results with Hers GLP-1

Most users notice appetite changes within the first two to four weeks, but visible weight loss typically becomes consistent between weeks four and twelve. Significant results, meaning five percent or more of body weight, generally appear by month three for adherent users.

Realistic timeline:

• Weeks 1-2: Mild appetite reduction, possible nausea as the body adjusts
• Weeks 3-6: Noticeable reduction in hunger, early weight changes of one to three pounds
• Months 2-3: Consistent weekly loss of one to two pounds, energy stabilization
• Months 4-6: Cumulative loss of 5-10% body weight for most users at therapeutic doses
• Beyond 6 months: Continued loss possible, but plateau management becomes important

---

Hers GLP-1 Prescription Requirements: How Do I Get It

Getting a Hers GLP-1 prescription is entirely online and does not require an in-person visit. The process is straightforward but does involve a real clinical review.

Step-by-step process:

1. Complete the online health intake form covering your medical history, current medications, and weight loss goals.
2. A licensed clinician reviews your responses and may follow up with questions via the platform’s messaging system.
3. If eligible, a prescription is issued for compounded semaglutide at the appropriate starting dose.
4. The medication ships directly to your home from a licensed compounding pharmacy.
5. Ongoing check-ins occur via the app to adjust dosing as needed.

You will not be approved if you have contraindications. This is a genuine clinical gatekeeping process, not an automatic approval system.

---

Hers GLP-1 vs Compounded GLP-1: What Is the Difference

Hers GLP-1 is itself a compounded GLP-1 program, so this comparison is really about Hers versus brand-name FDA-approved GLP-1 medications like Wegovy or Ozempic.

Key differences:

• Regulatory status: Brand-name semaglutide (Wegovy, Ozempic) is FDA-approved as a finished drug product. Compounded semaglutide from Hers is not, though it is legally dispensed by licensed compounding pharmacies.
• Cost: Compounded versions are substantially cheaper, often by hundreds of dollars per month.
• Insurance: Brand-name medications may be covered under some plans; compounded versions almost never are.
• Active ingredient: The semaglutide molecule is the same in both. The formulation, excipients, and manufacturing standards differ.
• Supply reliability: Brand-name medications can face shortage issues; compounding pharmacies have more flexibility to maintain supply.

For users exploring other compounded options, the Shed GLP-1 reviews and Directmeds GLP-1 reviews pages offer useful side-by-side context on competing telehealth programs.

---

Is Hers GLP-1 Covered by Insurance or Is It Out of Pocket

Compounded semaglutide through Hers is almost never covered by insurance. This is one of the most consistent points across Hers GLP-1 reviews, and it is important to factor into your decision.

Why insurance typically does not cover it:

• Insurance plans generally only reimburse FDA-approved finished drug products.
• Compounded medications fall outside standard formulary coverage.
• Even brand-name GLP-1 medications face coverage restrictions on many plans, often requiring prior authorization and documented comorbidities.

What this means for you:

• Budget for the full monthly cost as an out-of-pocket expense.
• Some users use HSA or FSA funds to offset costs, though eligibility depends on your specific plan.
• Check whether your employer’s benefits plan has any telehealth or preventive care provisions that might apply.

---

Hers GLP-1 Common Mistakes People Make When Using It

Several avoidable errors reduce results or increase side effects for Hers GLP-1 users. Knowing them in advance saves frustration.

• Skipping dose titration: Jumping to a higher dose too quickly dramatically increases nausea and dropout rates. Follow the prescribed escalation schedule.
• Not adjusting diet: Semaglutide reduces appetite but does not eliminate the need for a calorie deficit. Users who continue high-calorie diets see minimal results.
• Stopping at the first side effect: Most side effects peak in weeks two through four and then decline. Stopping early means missing the therapeutic window.
• Missing injections: Inconsistent dosing reduces efficacy. Set a weekly reminder and stick to the same day each week.
• Expecting immediate dramatic results: Weight loss on GLP-1 medications is gradual. Users who expect rapid transformation often quit before results materialize.
• Not disclosing all medications: Drug interactions are real. Always provide a complete medication list during the intake process.

---

Hers GLP-1 Weight Loss Results: Before and After Expectations

Setting realistic expectations is critical for long-term success with Hers GLP-1. Clinical data and real-world reviews point to consistent but gradual outcomes.

What is realistic:

• 5-10% body weight loss in the first three to six months for most adherent users
• Up to 15% or more over 12+ months at higher doses, consistent with trial data
• Plateau periods are common and do not necessarily indicate treatment failure

What is not realistic:

• Losing 30 pounds in one month
• Maintaining results after stopping the medication without lifestyle changes
• Zero side effects throughout the process

Real Hers GLP-1 reviews consistently show that the users with the best outcomes combine the medication with modest dietary improvements, regular movement, and patience. The medication is a tool, not a complete solution on its own.

For additional real-world data on semaglutide outcomes, the semaglutide reviews covering real results and side effects resource provides a broader base of patient experiences.

---

Hers GLP-1 Alternatives: Other Options Available

If Hers GLP-1 is not the right fit, several alternatives offer similar or complementary approaches to medically supervised weight loss.

• Henry Meds: Another telehealth platform offering compounded semaglutide; see the Henry Meds semaglutide review for a direct comparison.
• Medvi: Offers both semaglutide and tirzepatide options; the Medvi semaglutide reviews cover their program in detail.
• Ro Body: Gender-neutral telehealth platform with structured coaching alongside medication.
• Found: Combines GLP-1 prescriptions with behavioral coaching and community support.
• Noom Med: Pairs semaglutide prescriptions with Noom’s behavioral change curriculum.
• Tirzepatide programs: For users who want a dual GIP/GLP-1 agonist, tirzepatide may offer stronger results; see tirzepatide cost review for pricing context.

---

My Editorial Methodology

I did not personally take Hers GLP-1 for this review. My assessment is based on a systematic review of published clinical trials on semaglutide, analysis of user-reported experiences from Reddit, Trustpilot, and app store reviews, comparison of telehealth platform terms and pricing structures, and cross-referencing with FDA guidance on compounded medications.

I have no financial relationship with Hers. Where affiliate links appear elsewhere on this site, they are disclosed clearly. This review represents an independent editorial assessment intended to help readers make an informed decision.

Limitations: Compounding pharmacy quality can vary. I cannot independently verify the formulation consistency of any specific batch. Users should confirm that Hers sources from an FDA-registered 503B outsourcing facility or a licensed 503A compounding pharmacy.

---

Final Verdict: Is Hers GLP-1 Worth It

Hers GLP-1 is a legitimate, accessible, and reasonably priced entry point into medically supervised GLP-1 therapy for women who qualify. The clinical evidence for semaglutide is strong, the telehealth model lowers access barriers, and real-world Hers GLP-1 reviews suggest meaningful results for adherent users.

Consider it if:

• You are an adult woman with a BMI of 27 or higher
• You have not achieved adequate results through diet and exercise alone
• You are comfortable with weekly injections and an online-only care model
• You can budget for an ongoing monthly out-of-pocket expense
• You understand results take three to six months to fully materialize

Skip it if:

• You have contraindications to semaglutide
• You need in-person clinical monitoring
• You are expecting rapid or dramatic transformation without lifestyle changes
• The subscription model and lack of insurance coverage are financial barriers

Next steps: Complete the Hers online intake form to determine eligibility, review the current subscription terms carefully before entering payment information, and discuss the plan with your primary care provider if you have any existing medical conditions or take prescription medications.

---

Frequently Asked Questions

Is Hers GLP-1 safe?
For eligible users without contraindications, compounded semaglutide is generally considered safe based on the extensive clinical record of the semaglutide molecule. Side effects are common but usually manageable. Users with thyroid cancer history, MEN2, or pancreatitis history should not use it.

How long does Hers GLP-1 take to work?
Most users notice appetite reduction within two to four weeks. Consistent, measurable weight loss typically becomes visible between weeks four and twelve. Significant results (5%+ body weight) generally appear by month three.

Is Hers GLP-1 the same as Ozempic or Wegovy?
The active molecule, semaglutide, is the same. However, Hers uses compounded semaglutide, which is not an FDA-approved finished drug product. Ozempic and Wegovy are FDA-approved brand-name versions.

Can I take Hers GLP-1 with other medications?
Some medications interact with semaglutide, including insulin and other diabetes drugs. Always disclose your full medication list during the intake process. Consult your prescribing clinician or pharmacist if you are unsure.

What happens if I stop taking Hers GLP-1?
Weight regain is common after stopping GLP-1 medications, particularly if lifestyle changes were not made during treatment. Clinical studies show that a significant portion of lost weight returns within one year of discontinuation without behavioral support.

Is Hers GLP-1 a scam?
No. Hers is a legitimate, licensed telehealth platform. The medications are dispensed by real compounding pharmacies, and prescriptions are issued by licensed clinicians. It is not a supplement or over-the-counter product.

Does Hers GLP-1 require a prescription?
Yes. Semaglutide is a prescription medication. Hers provides access to a licensed clinician who reviews your health intake and issues a prescription if you are eligible.

Is there a money-back guarantee?
Hers has a refund policy, but terms vary. Review the current cancellation and refund terms on the official Hers website before subscribing, as these can change.

Who manufactures the compounded semaglutide for Hers?
Hers sources from licensed compounding pharmacies, but the specific pharmacy partners may change. Ask the platform directly whether their pharmacy is a 503B outsourcing facility for the highest quality assurance.

Can men use Hers GLP-1?
No. Hers is a women-focused telehealth platform. Men seeking GLP-1 programs should look at gender-neutral alternatives like Ro Body, Found, or Henry Meds.

---

Conclusion

Hers GLP-1 offers a practical, accessible path to medically supervised semaglutide therapy for women who qualify. The evidence base for semaglutide is among the strongest in weight management medicine, and real-world Hers GLP-1 reviews confirm that many users achieve meaningful results when they stay consistent and manage expectations realistically.

The program is not perfect. Side effects are real, the cost is entirely out of pocket for most users, and results require patience and lifestyle support alongside the medication. But for women who have struggled with weight loss and want a clinically grounded option without the barriers of traditional in-person care, it represents a credible choice.

Your next steps:

1. Check your eligibility by completing the Hers online health intake form.
2. Review the current subscription pricing and cancellation terms before entering payment details.
3. Talk to your primary care provider if you have any existing health conditions or take prescription medications.
4. Set a realistic three-month timeline and commit to modest dietary improvements alongside the medication.
5. Track your progress weekly and communicate with your Hers clinician if side effects are severe or results plateau.

---

References

• Wilding, J.P.H., et al. “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” New England Journal of Medicine, 2021. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
• Rubino, D.M., et al. “Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity.” JAMA, 2021. https://jamanetwork.com/journals/jama/fullarticle/2777886
• U.S. Food and Drug Administration. “Compounding and the FDA: Questions and Answers.” FDA.gov. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
• Shi, Q., et al. “Efficacy and Safety of GLP-1 Receptor Agonists in Overweight or Obese Adults Without Diabetes: A Systematic Review and Meta-Analysis.” Obesity Reviews, 2022.

---